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Abstract
Adverse neurodevelopmental outcomes are linked to perinatal production of inflammatory
mediators, including interleukin 6 (IL-6). While a pivotal role for maternal elevation in IL-6 has
been established in determining neurobehavioral outcomes in the offspring and considered the
primary target mediating the fetal inflammatory response, questions remain as to the specific
actions of IL-6 on the developing brain. CD-1 male mice received a subdural injection of the
bioactive fusion protein, hyper IL-6 (HIL-6) on postnatal-day (PND)4 and assessed from
preweaning until adulthood. Immunohistochemical evaluation of astrocytes and microglia and
mRNA levels for pro-inflammatory cytokines and host response genes indicated no evidence of an
acute neuroinflammatory injury response. HIL-6 accelerated motor development and increased
reactivity to stimulation and number of entries in a light/dark chamber, decreased ability to learn
to withhold a response in passive avoidance, and effected deficits in social novelty behavior. No
changes were observed in motor activity, pre-pulse startle inhibition, or learning and memory in
the Morris water maze or radial arm maze, as have been reported for models of more severe
developmental neuroinflammation. In young animals, mRNA levels for MBP and PLP/DM20
decreased and less complexity of MBP processes in the cortex was evident by
immunohistochemistry. The non-hydroxy cerebroside fraction of cerebral lipids was increased.
These results provide evidence for selective effects of IL-6 signaling, particularly trans-signaling,
in the developing brain in the absence of a general neuroinflammatory response. These data
contribute to our further understanding of the multiple aspects of IL-6 signaling in the developing
brain.
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Early inflammatory responses in the fetus and neonate may underlie a diverse range of long-
lasting effects on the nervous system (Hagberg and Mallard, 2005). The link between
maternal infection and adverse effects in the offspring is thought related to an increased
availability of maternal inflammatory factors and induction of a fetal inflammatory response
(Cai et al., 2003; Ashdown et al., 2006; Beloosesky et al., 2006; Dammann and O’Shea,
2008). This involves increased production of interleukin (IL)-1, -6, -8, and tumor necrosis
factor alpha (TNFα) in chorionic membranes, amniotic fluid, and fetal blood (Fidel et al.,
1994; Goepfert et al., 2004). Animal models support neuroinflammation with maternal
(Boksa 2010; Gayle et al., 2004; Meyer et al., 2009) or post-natal inflammatory challenge
(Cai et al., 2003; Pang et al., 2006) being associated with adverse effects on brain
development, myelination (Paintlia et al., 2004; Pang et al., 2003; Loron et al., 2011), and
behavior (Shi et al., 2003; Zuckerman et al., 2003; Bilbo et al., 2006; Meyer et al., 2006;
Ozawa et al., 2006). In each model, a diverse array of inflammatory responses occurs in the
dam or pup. Efforts to tease out critical causative inflammatory factors identified maternal-
derived IL-6 as a pivotal factor. In rodent lipopolysaccharide (LPS) models of gestational
infection, maternal derived IL-6 contributes to deficits in pre-pulse startle inhibition, latent
inhibition and social interactions (Samuelsson et al., 2006; Smith et al., 2007). The nature of
the effect shifts with age of exposure (Meyer et al., 2006). Exposure of the postnatal brain to
recombinant IL-6 showed did not recapitulate the LPS effects however, the co-
administration of an IL-6 neutralizing antibody was effective in blocking the LPS-induced
effects (Pang et al., 2006). These findings suggested that, while pivotal, the contribution of
IL-6 in developmental neuroinflammation might be related to the level of IL-6R expression
induced by co-expressed inflammatory factors.
Interleukin-6 (IL-6) is a pleiotropic cytokine mediating acute-phase responses, cell
regeneration, and transition from innate to acquired immunity. The biology of IL-6 is
complex with pro- or anti-inflammatory cytokine or neurotrophic actions, depending on the
signaling pathway activated (review, Scheller et al., 2011). In the classical pathway, IL-6
binds to a membrane bound IL-6R and the complex associates with gp130, for intracellular
signaling. gp130 is present on most neural cells; however, IL-6R expression is restricted in
the brain thus, the potential of IL-6 to act through its classical cognate receptor is limited. In
trans-signaling, cells expressing only gp130 and lack membrane bound IL-6R can be
activated by IL-6/soluble IL-6R (sIL-6R) complex (Jones et al., 2005; Rose-John et al.,
2007). Thus, shedding of sIL-6R by neighboring cells upon stimulation as would occur with
inflammation and interactions of the IL-6/sIL-6R complex with gp130 provides IL-6
sensitivity to many cell types that do not express IL-6R; expanding biological effects.
Existing data implicating IL-6 in developmental effects of neuroinflammation suggests a
role for sIL-6R in subsequent brain damage. However, the existing studies do not address
whether an excess of IL-6 in the absence of other inflammatory related factors would
produce similar adverse effects. To examine such effects of excess IL-6 trans-signaling, we
exposed the early postnatal brain to the bioactive fusion protein, hyper IL-6 (HIL-6), a
chimera of recombinant human IL-6 bound to IL-6Rα by a short peptide chain (Fischer et
al., 1997). Compared to IL-6/IL-6Rα, HIL-6 has a 100-fold higher receptor binding affinity
and while the half-life (approx. 2 hrs) is similar to IL-6, HIL-6 has an enhanced and longer
activation of the transcription STAT3-dependent and mitogen-activated protein kinase
pathways (Rakemann et al., 1999). We now report direct effects on the developing brain; but
unlike the broad spectrum of effects attributed to classical IL-6 signaling with high levels of
inflammation, direct subdural exposure of the brain to HIL-6 in post-natal day 4 mice,
results in subtle alterations evident in cortical white matter development, motoric
development, and long-term effects on reactivity and social behavior.
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Animals and Hyper IL-6 injection
On postnatal day (PND) 1, [day of birth PND0], litters of 8–12 CD-1 pups (Charles River;
Raleigh, NC) were pooled and 10 males were randomly selected and placed with each foster
dam. Selected as an age of the developmental transition of OL progenitor cells (pre OLs) to
an immature OL, comparable with the human 24–28 weeks of gestation (Craig et al., 2003),
PND4 pups were injected with either saline vehicle or HIL-6 on PND4. One-half of the pups
were removed and maintained at 35°C. Under cold anesthesia, each pup was visualized on a
back-lit stage and, under 2× mag, a 30-g needle was inserted at a 10° angle through the skin
and dura overlying the open posterior fontanel (junction of lambdoidal suture and sagittal
suture) along the sagittal fissure and 2μl of either phosphate buffered saline (PBS; pH 7.2)
vehicle or HIL-6 (5 or 10ng; gift of Stephan Rose-John, Hamburg, Germany) was injected
into the subdural cavity over 30sec via a syringe pump. Pups were tattooed, recovered at
35°C (20 min), then returned to the dam and a counterbalanced sequence repeated with
remaining pups. Normal maternal/pup interactions and pup survival (1% acute mortality;
<1% subsequent morbidity) were maintained. Multiple cohorts of 6 litters were generated
with pups assigned to endpoints at injection. With terminal pre-weaning endpoints, age-
matched filler mice were used to maintain litter size. At PND21, littermates were housed,
one pup/dose, in a semi-barrier animal facility (21°±2°C; 50%±5% humidity; 12-h light/
dark cycle). For euthanasia, mice were anesthetized with CO2, decapitated, the brain
excised, and the parietal/temporal cortex and hippocampus dissected (Glowinski and
Iverson, 1966) from one hemisphere, rapidly frozen, and stored at −80°C. The contralateral
hemisphere was immersion fixed in 4% paraformaldehyde/phosphate buffer pH 7.2 for
18hrs. All procedures complied with UNC/CH and NIEHS/NIH ACUC approved protocols.
Dose selection was based upon in vitro studies demonstrating activity in HepG2 cells (Peters
et al., 1998), neurite outgrowth and branching (Schafer et al., 1999), and induction of glial
processes (data not shown). Pilot studies of tracer dye distribution and indications of STAT3
activation from the microarray (Suppl. Fig. 1) suggested delivery of a biologically active
substance to the cortex.
Experimental design
In pilot studies, one cohort was used to assess damage from HIL-6 (5 and 10 ng) and to
determine age brackets for pre-weaning functional assessments. For terminal endpoints
(mRNA analysis, histopathology, protein or lipid analysis), animals were randomly selected
from various cohorts. Histopathology, immunohistochemistry, and myelin lipids were
examined at both dose levels; given the similarity, data is presented for the 5ng dose. The
microarray was conducted at the higher 10ng HIL-6 dose to ensure detection of changes
using the less sensitive array procedure. qRT-PCR for myelin specific genes, host response
genes and pro-inflammatory cytokines were conducted on the 5ng dose group. Post-weaning
assessments were conducted at 5ng HIL-6. The litter determined the n size with only one
pup/litter/dose/endpoint.
Preweaning neurodevelopmental assessment
Based upon data from a pilot study (see Suppl. Material), a modified Fox battery (Fox,
1965; Brunssen et al., 2010) was administered on PND8, 12, and 16. Pup weight, nose-rump
length, and presence of physical development parameters were recorded. Posture,
locomotion, and motor behaviors were observed in an open field. Reflex responses, postural
reactions, and strength were assessed. Physical development parameters (vibrissa present,
eyelids open, pinna separated, incisors erupted) were scored as absent/present (0,1). Changes
in fur distribution [0–4], fur type, posture, locomotion (pivot/crawl, linear/walk), reflexes
and postural reactions (cliff aversion, surface or aerial righting, placing responses, fore- and
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hind-limb grasp, and auditory startle), kinesthetic response (general fine body tremors) [0–3]
and over-generalized response to testing [0–4] were described on ordinal scales. Motor
behaviors (sitting, grooming, rearing, running, jumping, and slope exploration) were scored
as absent/present (0,1). The pup’s ability to grasp a thin metal bar and hold its weight for
15sec max or grasp and climb an inverted wire mesh screen (30 sec max) were measured.
Summary scores were created for dichotomously scored variables for physical development
(0–4), normal motor (0–3), and heightened motor (0–3) behaviors and analysis restricted to
correlations between item scores and HIL-6 level at each age. At PND18 general locomotor
activity levels were measured in an open field as sector crosses over 2 min.
Histology and immuohistochemistry
Injury in the cortex and hippocampus was evaluated by hematoxylin and eosin (H&E)
staining and immunostaining of astrocytes and microglia. Six-μm paraffin sagittal sections
underwent heat-induced epitope retrieval (0.01M citrate buffer pH 6.0; Biocare Medical,
Walnut Creek, CA). Sections were blocked with non-immune goat serum (1:50; 10min)
prior to 60-min incubation with rabbit anti-cow glial fibrillary acidic protein (GFAP;
1:2000; Dako Corp, Carpinteria, CA), 60 min avidin/biotin reagent (1:100; ABC; Vector
Labs, Burlingame, CA), and detected with diaminobenzidine (DAB). Microglia were
identified with a rabbit polyclonal antibody to ionized calcium-binding adaptor molecule 1
(Iba-1, 1:500, 1hr, 24°C; Wako Chemicals, Richmond, VA).
mRNA levels for host-response and pro-inflammatory cytokine genes
To evaluate whether the HIL-6 injection resulted in injury and secondary inflammatory
response in the cortex, pro-inflammatory and host-response injury genes were examined by
RNAse protection assays as previously described (Harry et al., 2003). Within one day of
injection (PND5) and at 1-week post-injection (PND11), total RNA was isolated with
Trizol™ (Gibco BRL, Gaithersburg, MD). 32[P]-labeled cRNA probe sets contained probes
for genes associated with a host-response to injury (Campbell et al., 1994): intercellular
adhesion molecule-1 (ICAM-1), inducible nitric oxide synthetase (iNOS), A20 (cytokine-
inducible response gene), macrophage-1 antigen (Mac-1), EB22 (acute-phase response
gene), and GFAP, or pro-inflammatory cytokines and receptors: IL-1β, IL-1-receptor 1
(IL-1R1), IL-1RII, IL-1 receptor antagonist (IL-1ra), IL-1α, and IL-10; or TNFα, TNFβ,
TNF receptor 2 (TNFRp75), TNFR1 (TNFRp55), IL-6Rα, gp130, and IL-6 (BD
Pharmingen, San Diego, CA). Relative volume of each 32[P]-fragment was determined from
phosphor-imaging (Imagequant; Molecular Dynamics, Sunnyvale, CA) and normalized to
corresponding L32.
For the hippocampus, we examined mRNA levels for TNFα, IL-1α, IL-1β, IL-6, and IL-10
mRNA levels at PND5 by qRT-PCR (7900 HT, Applied Biosystems; Foster City, CA) using
2.5μg 77cDNA as template, 1X Power SYBR® Green Master Mix (Applied Biosystems),
and forward and reverse primers (Suppl. Table 1). Threshold cycle values were determined
from amplification curves, normalized to GAPDH, and mean fold changes over the control
group calculated using the comparative CT method.
Microarray analysis
At PND8 total RNA was isolated from the cortex with Tri-Reagent (Sigma-Aldrich, St.
Louis, MO) and purified (Qiagen RNEasy mini-columns; Qiagen, Valencia, CA). Samples
(n=3) were pooled from 2 non-littermates and 10μg of cRNA was hybridized to the
Affymetrix 430 A 2.0 mouse array (Affymetrix, Sunnyvale, CA; Suppl Material). Data was
analyzed by a modified t-statistic, using the observed mean-variance relationship in each
sample to construct estimates of group variances (Hu and Wright, 2007). Selection criteria
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required a minimum 2-fold change and p<0.01. Pathway analysis and network associations
were determined using IPA (Ingenuity Systems, Inc, Redwood City, CA).
Myelin assessment
The mouse forebrain begins to form myelin at approximately PND10-12, preceded a couple
of days by an induction of mRNAs related to oligodendrocyte (OL) progenitor cell (OPC)
proliferation and myelin proteins. Myelin basic protein (MBP) levels were examined at early
accumulation (PND16), peak level of accumulation (PND24), and in the adult (Vincze et al.,
2008),
qRT-PCR for myelin related genes—Total RNA was isolated from the cortex (n=12)
and 3μg used to generate a 2.5μl cDNA aliquot. Sybr Green PCR Master Mix (Applied
Biosystems, Foster City, CA) was used with primers for a marker for oligodendroglia
progenitors; integral membrane chondroitin sulfate proteoglycan protein, neuron-glia 2
(NG2) pre-OLs, proteolipid protein (PLP/DM20), late OL maturation and axon contact,
myelin associated glycoprotein (MAG), and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (Suppl. Table 1).
Western blotting—30μg protein was subjected to electrophoresis on 4–12% NuPage®
Bis-Tris gels (Invitrogen) and 0.2 μm NuPage® polyvinlyidene difluoride membranes were
incubated in rabbit polyclonal anti-MBP (1:2000; 1h, RT; Sigma M3821) then anti-rabbit
IgG horseradish peroxidase conjugated antibody (1:50,000; 1h, RT; Santa Cruz Biotech).
Membranes were probed with ECL plus (Amersham Biosciences, Arlington Heights, IL)
and digital images analyzed (GeneTools version 4.01; Synoptics, Frederick, MD).
Membranes were stripped and re-probed with rabbit polyclonal anti-actin (1:5000; 1h, RT;
Sigma).
MBP immunohistochemistry—Serial 6μm paraffin sagittal sections were matched for
position in the forebrain through the anterior commissure, hippocampal fimbria, and corpus
callosum. Sections were blocked with non-immune goat serum (1:50; 10 min), incubated
with rabbit anti-MBP (1:500, 20hr, 4°C; Chemicon, Danvers, MA), biotinylated goat anti-
rabbit secondary antibody (Chemicon) followed by an AKP ABC complex (Vector Labs,
Burlingame, CA), and detected with Nitro-Blue tetrazolium chloride/5-bromo-4-chloro-3′-
indolyphosphate p-toluidine salt (NBT/BCIP; Roche, Nutley, NJ).
Lipid extraction and HPLC analysis—Developmental changes in myelin glycolipid
synthesizing enzyme follow a rapid increase between PND14 and 20 followed by a
stabilization period (Hof and Csiza, 1982). Total lipids were extracted from the forebrain of
PND26 mice (n=3) as an early plateau stage, and analyzed by HPLC as previously reported
(Muse et al., 2001). Total cerebrosides (hydroxy fatty acid [HFA] and non-hydroxy fatty
acid [NFA] galactosyl-ceramides), as well as their sulfated derivatives, sulfatides and
cholesterol were expressed as nM/mg tissue weight.
Behavioral assessments
Between PND23 and PND25, individual groups of mice were tested for light/dark place
preference, passive avoidance, and pre-pulse startle inhibition (PPI) (San Diego Instruments,
San Diego, CA). Adult mice were assessed for motor activity, social behavior and social
novelty. Pre-weaning observations were made on all mice. Mice behaviorally-tested as
adolescents were not assessed as adults. Any prior testing experience in adults is indicated.
The Morris water maze and win-shift radial arm maze assessments were each conducted on
independent groups of animals.
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Light/Dark place preference—Mice (n=12; PND23) were tested using a modified
(white walls in lighted chamber) Gemini II shuttle box to assess activity, anxiety level, and
response to a novel environment. Mice were placed in the start chamber, the gate raised and
free movement allowed for 10min. The number of entries into the darkened chamber,
average duration per dark chamber entry, and total time spent in the dark chamber were
recorded.
Passive Avoidance—Mice (n=16–18; PND22-23) received one training session and one
test session 24hrs later using a Gemini II shuttle box. Mice were allowed 60sec acclimation
to the lighted “safe” side, the gate opened and entry into the dark chamber initiated gate
closure and a 3sec scrambled foot shock (0.4mA). The pup remained in the dark
compartment for 10sec. This was repeated in the test session. Latency to cross to the dark
side was recorded.
Startle and PPI—Mice (n=12; PND25; previously assessed on light/dark test) were
assessed for auditory startle response, habituation, and PPI as a measure of sensorimotor
gating. Following 5-min habituation, the test session consisted of 42 trials presented with
15-sec variable inter-trial interval (ITI) in blocks of 7 with 70dB background. Session trials
were comprised of no-stimulus, acoustic startle stimulus (40msec; 120 dB) alone, and pre-
pulse stimulus trials (20msec pre-pulse [4,8,12,16, or 20dB above background], 80msec gap,
and 40msec pulse). Startle amplitude was collected across a 65msec sampling-window. PPI
was calculated [(1 - response amplitude for prepulse stimulus plus startle stimulus/response
amplitude for startle stimulus alone) × 100].
Locomotor Activity and Rearing—On PND120, mice (n=12) were evaluated for
exploratory activity in a photocell activity chamber (40cm × 40cm × 30cm). Total
ambulatory activity and vertical activity (rearing) were determined in 5-min epochs over a
60-min session.
Social Behavior—At PND140, mice (n=12; previously assessed for activity) were
evaluated in a 3-chambered open-access clear plexiglass box to assess social behavior
(approach to unfamiliar mouse) and social novelty (preference of a stranger to known
mouse). The test consisted of three 10-min phases: habituation, social approach, and social
novelty (Moy et al., 2006; Suppl. Material). Time spent in each chamber, number of
transitions between chambers, and time spent sniffing wire cage with or without stranger
mouse were recorded. Olfactory function was screened by the latency to identify and
consume buried novel food (Froot Loops, Kellogg, Battle Creek, MI).
Radial Arm Maze (RAM)—On PND80, mice (n=6) were acclimated to handling and
chocolate-flavored food pellets (Bioserve, Frenchtown, NJ). Following overnight food
restriction, each mouse freely explored a baited maze until all 8 pellets were retrieved within
300sec (4–5 sessions). To assess working and reference spatial memory, acquisition of the
win-shift task (win food, shift to new location) over 15 daily 5-min sessions with each arm
baited (Levin et al., 2004). Pellet retrieval, number of baited arms entered until the mouse
made an error and reentered a prior arm, latency per entry, and a measure of random choice
(proportion incorrect = # incorrect arms/total # arms entered) were recorded by two
observers at >90% inter-rater reliability. Trials with fewer than five arms entered were
considered failed trials. Animals were maintained at 80% free-feeding body weight.
Morris water maze (MWM)—At PND180, mice (n=12; previously assessed for activity)
were assessed for spatial learning and reference memory. A water-habituation trial was
followed by 4, 1-min trials/day (10-min ITI) over 4 days, to learn location of a submerged
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platform. Latency to find the platform, swimming distance, and swimming velocity were
recorded (Noldus Ethovision, Leesburg, VA). On day 5, a 1-min probe trial was conducted.
A 4-trial retention test was conducted 17 days later followed by 4 days of reversal learning
of a different platform location.
Statistical analysis
Spearman’s Rank Order Correlation for cross-sectional measures tested ordinal variables in
the neurodevelopment assessment. Within-subject repeated measures (weight, length, RAM)
were tested using General Linear Mixed Models (SAS). Repeated Measures ANOVAs were
used for locomotor activity, PPI, and MWM. Light-dark place preference and MWM probe
trial were analyzed by Student’s t-tests and passive avoidance by Mann-Whitney U.
Cerebroside and cholesterol levels were analyzed by one-way ANOVAs. RPAs and qRT-
PCR data were analyzed by ANOVAs for treatment, age, and interaction effects. Post-hoc
pairwise comparisons were made by Fisher’s PLSD or Student’s t test with Bonferroni
correction following a significant overall ANOVA or HIL-6 main effect. Significance was
set at p≤0.05.
RESULTS
Acute histological response to HIL-6 injection
Histological examination of the brain within the first week following injection confirmed the
absence of an injury response due to the procedure or to HIL-6. In the cortex, a few eosin+
cells could be observed within localized areas and was considered within the normal control
range (Suppl. Fig. 2A). GFAP staining of astrocytes displayed cells with thin ramified
processes (Suppl. Fig. 2B) and Iba-1 microglia showed no evidence of activation (Suppl.
Fig. 3). No HIL-6 induced changes in H&E, GFAP, or Iba-1 were observed in the
hippocampus (Suppl. Fig. 4) or any other brain regions located within the plane of cut.
Observation assessments during pre-weaning development
No differences were seen in body weight, length, or brain weight (data not shown). In the
pilot study, age-dependent appearances of physical developmental landmarks were similar
across groups. HIL-6 mice demonstrated earlier onset of straight line walking, earlier loss of
cliff aversion, later onset of coordinated forelimb grasp and elevated motor reactivity to
sensory stimulation and handling (Suppl. Table 2). In the subsequent cohorts, these findings
were confirmed. Compared to controls, HIL-6 mice showed persistence of hyperkinesias at
PND12 (Fig. 1A). On PND8, control mice maintained an immature pivot locomotor
response [Spearman’s ρ(34)= −0.339, p=0.047] (Fig. 1B); while, HIL-6 mice showed an
earlier onset of straight line walking [ρ(34)=0.334, p=0.05] (Fig. 1C). Developmental onsets
of spontaneous motor behaviors (sitting, grooming, rearing) were similar across groups (Fig.
1D). Heightened motor activities in HIL-6 mice showed a general trend for increase
frequency across PND12 [ρ(34)=0.303, p=0.076] and PND16 [ρ(35)=0.421, p=0.011] (Fig.
1E). Increased general reactivity to handling was observed at PND8 [ρ(34)=0.523, p=0.001],
PND12 [ρ(34)=0.519, p=0.001], and PND16 [ρ(35)=0.465, p=0.004] (Fig. 1F). An
exacerbated startle response was observed in HIL-6 mice at PND12 [ρ(34)=0.483, p=0.003]
and PND16 [ρ(35)=0.394, p=0.019] (Fig. 1G). At PND 18 no significant difference was
observed in open-field activity level (data not shown).
qRT-PCR of inflammatory-related cytokines in the hippocampus
Consistent with the absence of a microglia response in the hippocampus, qRT-PCR
indicated no significant differences in mRNA levels for TNFα, IL-1α, IL-1β, IL-6 while
mRNA levels for IL-10 showed a significant increase in the HIL-6 mice at PND5 (Fig. 2).
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Lack of elevated inflammatory cytokine mRNA in the cortex
To evaluate whether an acute cellular injury and associated inflammatory response was
induced by the HIL-6 injection during the first week, RPAs were conducted on cortical
tissue at PND5 and 11 (24hr and 1wk post-injection). Significant age effects were seen for
MAC-1 [F1,6 =15.65, p=0.007] and EB-22 [F1,6= 21.7, p=0.003] (Fig. 3A). mRNA levels
for IL-1RII, IL-1Ra, IL-10 (Fig. 3B), TNFα, and TNFβ (Fig. 3C) were similar across age.
IL-1β showed a slight increase at both ages in the HIL-6 dose group however, it failed to
reach statistical significance. Significant increases between PND5 and 11 were detected for
IL-1R1 [F1,17 = 6.28, p = 0.023], IL-1α [F1,17 = 18.61, p<0.001] (Fig. 3B), TNFRp55 [F1,15
= 16.63, p=0.014], gp130 [F1,15=32.62, p=0.001], and IL-6 [F1,15 = 20.5, p=0.001] (Fig.
3C). No HIL-6 treatment related effects were detected (Fig. 3A–C).
Microarray analysis of cortex
Samples examined at PND8, 96 hrs post-HIL-6 injection, showed altered levels for a
number of mRNA transcripts. Criteria for selecting genes required a minimum of 2-fold
change with p<0.01. Consistent with the RPA analysis there was no indication of an
inflammatory response initiated by HIL-6. A total of 1164 mapped genes were altered, 373
were lower and 791 were higher. Since we were examining for all of the significant
functions in the dataset, we used a Benjamini-Hochberg multiple testing correction and the
glutamate receptor signaling and the axonal guidance signaling pathways emerged as the top
canonical pathways affected. The genes showing the highest level of fold-change in the
HIL-6 mice compared to controls were molecules of diverse function (Table 1). Data
indicated that the injection of HIL-6 induced an elevation in genes associated with activation
of the STAT3 signaling pathway (Fig. 4A). With regards to myelin related genes, the
microarray profile suggested a change in genes related to OL maturation and myelination as
indicated by network linkage via MBP (Fig. 4B). HIL-6 did not alter mRNA levels for
chondroitin sulfate proteoglycan, a marker for early neuroglia precursors, nor NG2. Myelin-
associated oligodendrocyte basic protein (MOBP) was decreased by 2.8 fold. This was
accompanied by a 7.9-fold decrease in MBP and a 3.7-fold decrease in myelin proteolipid
protein (PLP). mRNA levels for enzymes involved in lipid hydroxylation and turnover and
believed to be uniquely expressed in OLs, fatty acid-2 hydroxylase, UDP-
galactosyltransferase, as well as Ugt8a were decreased in the HIL-6 mice.
qRT-PCR for myelin genes in the cortex
When we examined mRNA levels for selected myelin related genes by qRT-PCR (Fig. 5A),
no changes were observed in the marker for OL precursors, NG2, from PND5 to 16. PLP
and its alternatively spliced isoform DM20 are main intrinsic membrane proteins of compact
myelin with essentially identical mRNA developmental profiles (LeVine et al., 1990).
Similar to changes observed in PLP in the microarray, qRT-PCR mRNA levels for PLP/
DM20 were decreased 0.6 to 0.8 fold across all three ages in HIL-6 mice (main effect for
HIL-6 [F1,27 =6.2, p=0.02]; post-hoc analysis showed a significant decrease at PND24
[t9=3.04; p=0.014]. For MAG, a protein developmentally associated with late OL maturation
and signaling between the axon and myelin (McKerracher et al., 1994), mRNA levels
increased 1.3 to 1.5 fold and a significant main effect of HIL-6 was observed across the
developmental window [F1,28 =4.44, p=0.045; Fig. 5A].
HIL-6 increased NFA-cerebroside fraction
Cerebroside (galactosyl-ceramide; GalC) is a major myelin component providing a rapid and
sensitive index of myelin deposition, with a peak rate of deposition and ceramide
galactosyltransferase mRNA expression between 3–4 weeks of age (Muse et al., 2001).
Total cerebroside levels were not significantly different between groups. The control levels
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of sulfatides (57+7 nM/mg tissue wt) and HFA-cerebrosides (38±6 nM/mg tissue wt), as
percent of total cerebrosides, were not significantly altered by HIL-6. The NFA-cerebroside
fraction was significantly increased (2.5-fold) in HIL-6 mice (Fig. 5B, [F2,6=7.28; p=0.025])
resulting in a decreased ratio of HFA:NFA-cerebrosides (controls: 7.88; HIL-6: 2.3). Total
cholesterol was not altered (control: 18.4+3.4 nM/mg tissue weight; HIL-6; 17.9±2.0 nM/
mg; p=0.98).
Myelin Basic Protein
Protein levels of MBP showed a normal increase across development from PND16 to adult
by both Western blot and immunohistochemistry. Western blots showed no indication that
HIL-6 exposure decreased the total amount of MBP (data not shown). However, the pattern
of MBP staining indicated differences. Myelinated tracts were detected within the corpus
callosum, cortex, and fine linear processes within the frontal lobe at PND16 (Fig. 5C). In the
HIL-6 mice, staining in the corpus callosum suggested a denser packing of myelinated fibers
with approximately 25% +/− 5% decrease in width. Myelinated projections into the cortex
visually displayed less branching complexity (Fig. 5C; Suppl. Fig. 5). At PND24, MBP
staining was not as compact in the corpus callosum as observed at PND16 and no
differences in width were detected. An age-related increase in complexity of the myelinated
fibers within the cortex was observed in both groups (Fig. 5D). Visual representation
suggested a diminished level of complexity of myelinated processes in the HIL-6 mice (Fig.
5D). This was especially evident in the projections from the corpus callosum to the cortex.
The overall evaluation of the frontal lobe suggested a similar effect; however, this was
variable across animals and showed no specific deficit in HIL-6 mice. In the adult, MBP
staining was similar between the HIL-6 mice and controls with a further increase in process
complexity occurring with maturation; however, we were unable to visually detect a change
in HIL-6 mice (data not shown).
HIL-6 altered behavioral performance
Light/dark place preference—HIL-6 mice showed a significant increase in the number
of entries into the dark chamber [t20=3.8; p=0.003] (Fig. 6A) and duration from each entry
was significantly less as compared to controls [t14=3.14; p=0.004] (Fig. 6B).
Passive avoidance—Passive avoidance examines the ability to learn to inhibit a normal
escape response and invokes higher cortical circuits involving modulation of emotion and
fear responses to adverse stimuli. In the initial training session for passive avoidance, no
difference was observed in the latency to enter the preferred dark chamber as a function of
HIL-6 administration (Fig. 6C). In the test session, HIL-6 dosed mice showed a significant
deficit with a lower latency to enter the dark chamber [Mann-Whitney U= 61; p=0.0009
one-tailed] (Fig. 6C) suggesting a hindered ability to learn to withhold this normal response.
Pre-pulse startle inhibition—Startle amplitude to 120 dB stimulus (Fig. 7A) did not
differ between controls and the HIL-6 mice [F1,21= 1.35, p=0.258]. Both showed the
expected reduction in amplitude across increasing prepulse levels [F5,110= 58.43, p<0.0001]
(Fig. 7B). Amplitudes in HIL-6 mice were maintained at 17% above controls but did not
reach statistical significance [F1,110= 1.05; p=0.307]. Both groups showed the expected
change in PPI across increasing prepulse levels [F4,88=56.95; p<0.0001] but no significant
difference between controls and HIL-6 mice was observed [F1,88=0.22; p=0.644].
Social behavior—Social approach behavior was not altered by HIL-6. All mice showed
normal preference for the stranger mouse versus an empty cage in presence time in chamber
with stranger [p<0.05] (Fig. 8A) and time spent sniffing the stranger [p<0.001] (Fig. 8B). In
the test for social novelty, control mice showed a preference for the newly introduced
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stranger, spending approximately 35% greater time in this chamber and a significant
increase in time spent sniffing stranger 2 [t11=3.17, p<.01] (Fig. 8C,D). HIL-6 injected mice
failed to demonstrate a preference for stranger 2 on either measure (Fig. 8C,D). Latency to
find novel buried food indicated intact olfactory function in both groups (data not shown).
Locomotor activity—Locomotor activity levels were similar across groups. All mice
showed a normal pattern of habituation across the 60-min test session in both distance
travelled and number of rearing events (Fig. 9A–B).
Morris Water Maze—Total acquisition, latency to find platform during training, was not
significantly altered by HIL-6 (Fig. 9C). In the probe trial, all adult mice showed a
significantly greater proportion of time spent in the target quadrant [p<0.05] (Fig. 9D). No
differences were observed for swimming distance or in swimming velocity during the test
sessions (data not shown). When mice were tested for the ability to shift their response to a
new quadrant, no significant difference was observed between the HIL-6 treated mice and
controls in the latency to find the platform in the 4-day reversal task (Fig. 9E).
Radial-arm maze—Mice exposed to HIL-6 did not differ significantly from controls in
acquisition of the 8-arm radial-maze task. In both groups, the mean number of consecutive
correct choices prior to making an error increased from 4 (random) to a peak performance of
7 after 10 days of training (F1,165=23.1, p<0.0001). The proportion of incorrect choices
declined from 40% to ~20% for both groups by day 10 (F1,165=11.2, p=0.007). As a general
pattern, the acquisition of speed for arm choices (latency/entry) differed by HIL-6 treatment
over the 15 training sessions (F1,154=4,70, p=0.032; HIL-6 by day quadratic interaction;
GLM). HIL-6 mice displayed a more rapid latency (mean=20 sec) than controls (mean=27
sec) during the initial sessions. Both groups achieved maximum speed (~9sec) following one
week of training (F1,153=0.05, p=0.82).
DISCUSSION
Recent work suggests IL-6 as a critical factor for altered neurodevelopment associated with
early-life inflammation; however, it is also suggested that effects attributed to IL-6 may be
dependent upon co-expression of other inflammatory factors or the developmental window
of exposure. We now demonstrate that early postnatal exposure of the brain to HIL-6, in the
absence of elevations in TNFα and IL-1 or neuronal death, produces subtle changes in
specific aspects of neurobehavior. This is in contrast to the broad effects previously
attributed to IL-6 under more severe inflammatory conditions. HIL-6 mice displayed a
premature emergence of locomotor responses and motoric responses and elevated reactivity
to environmental stimuli. Deficits in place preference and passive avoidance were observed
in juvenile mice and a reduced preference for social novelty in adults. Unlike previous
studies, no alterations were found in motor activity and spatial learning and memory
performance with the exception of a more rapid initial training latency in the RAM. Subtle
changes were observed in oligodendroglia and myelin specific genes and NFA-cerebroside
fraction during the pre-weaning and adolescent period with no evidence of a decrease in
myelin basic protein but a slight transient alteration in the complexity of myelinated
processes suggesting an effect on the developing OL similar to previous observations in
perinatal infection models (Roberson et al., 2006).
The majority of earlier studies demonstrating a profound impact of gestational infection on
offspring behavior utilized models with elevated maternal inflammatory factors and reported
a disruption in a number of neurobehavioral endpoints (Samuelsson et al., 2006; Smith et al.,
2007; Ito et al., 2010). These studies not only represent an earlier time in brain development
as compared to the current study but also a more severe and broad-spectrum inflammatory
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response as they examined acute/sub-acute relatively high-dose LPS effects. The
vulnerability of the brain and specific cellular targets can change with development;
however, neurotoxicity from LPS is not necessarily dependent upon gestation as a time of
exposure as similar effects in rodents have been observed with postnatal exposure. Given
that IL-6 has been considered the primary cytokine involved in these responses, Pang et al.
(2006) compared effects of exposure to IL-6 with those following LPS and found no similar
manifestation of neurotoxicity. However, upon co-administration of IL-6 neutralizing
antibody, the LPS effect was attenuated, suggesting a dependency upon interactions with
other LPS-related factors to stimulate IL-6R expression or shedding of soluble IL-6R for
biological activity. It can be speculated that involvement of sIL-6R may account for the
differences observed within the literature with regards to the contribution of IL-6 to
neurodevelopmental effects. Signaling via the IL-6/sIL-6R complex under inflammatory
conditions would be similar to HIL-6 in that it would be active on cells that did not normally
express IL-6R. One major difference would be that, with HIL-6, signaling would occur in
the absence of other inflammatory factors or microglia activation. Thus, using HIL-6
allowed us to identify the unique contribution of IL-6 to these neurodevelopmental
alterations. If indeed, an acute exposure of the developing brain to IL-6 signaling can
produce alterations in behaviors that are often associated with human neurodevelopmental
disorders, as seen in the current study, this raises a level of clinical concern for lower levels
of exposure than previously considered. A further understanding is needed of the
contribution of trans-signaling versus classical IL-6 signaling to neurodevelopmental
inflammation and subsequent behavioral alterations. It is possible that as a natural inhibitor
to prevent IL-6/sIL-6R complex from interacting with membrane-bound gp130 (Heinrich et
al., 2003), soluble gp130 could potentially be used to elucidate such contributions. This
would then allow for the further evaluation of sIL-6R as a potential therapeutic target for
early post-natal immune-mediated response in the brain.
The selective behavioral impairments found in the present study suggest that exposure to
HIL-6 led to alterations in the developmental trajectory, with improvement emerging in
adulthood. In the present study, neonatal HIL-6 mice exhibited transition from pivoting to
straight-line walking at a significantly earlier age than controls, suggesting the possibility of
a similar accelerated maturation of motor areas. Something similar was observed in an LPS
model of intrauterine inflammation in the rat with offspring showing an earlier proficiency
of forelimb placement and surface righting than controls (Poggi et al. 2005) and in improved
motor performance in a postnatal LPS inflammatory rat model for cerebral palsy (Roberson
et al., 2006). Alterations in the developmental trajectory of the cortex have also been
identified in humans. For example, the longitudinal assessment of children with attention-
deficit/hyperactivity disorder (ADHD) has revealed general delays in cortical maturation
yet, accelerated maturation in the primary motor cortex (Shaw et al. 2010).
The neonatal and adolescent HIL-6 mice exhibited several phenotypes in line with impaired
development of response inhibition and impulse control, including increased activity in the
light/dark task, hyper-reactivity to handling and acoustic stimuli, and decreased latencies in
the passive avoidance task. However, few abnormal behaviors were observed in the adult
HIL-6 mice. In a non-human primate model of moderate self-limiting bacterial infection
induced by LPS (2ng/kg/iv on GD 125 and 126), IL-6 levels over 2 days were only
moderately elevated yet at 2 months of age, these animals displayed a heightened level of
responsiveness (Willette et al., 2011). In ADHD, delayed maturation of the anterior
cingulate, striatum, and medial temporal lobes has been associated with age-dependent
deficits in response inhibition (McAlonan et al. 2009). Shaw et al. (2010) found that the
most severe maturational delay in ADHD was in the lateral prefrontal cortex, another brain
region thought to be important for impulse control. The early behavioral abnormalities in the
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HIL-6 mice could reflect a similar shift in maturation of higher-order cortical regions critical
for appropriate response inhibition.
One aberrant phenotype observed in the adult HIL-6 mice was a loss of social novelty
preference, without changes in sociability. Motivation in the social novelty task includes a
general preference for social proximity and a more specific preference for social novelty, as
well as the ability to discriminate between a newly introduced stranger and an already-
investigated stranger. Thus, performance in this phase of the task reflects more complex
motivation and demands than the sociability phase. Several genetic mouse models for
neurodevelopmental disorders have selective deficits in social novelty preference (Moy et al.
2009; O’Tuathaigh et al. 2007; Pietropaolo et al. 2011; Radyushkin et al. 2009).
Hemispheric connectivity might be especially important for responses during complex social
encounters that involve rapid information processing across different brain regions and have
been implicated in human neurodevelopmental disorders associated with altered social
behavior (Minshew and Williams, 2007). In the present study, exposure to HIL-6 led to age-
dependent reductions in the width of the corpus callosum and complexity of myelinated
fibers, which may be relevant to the disruption of complex social behavior observed in the
current study.
It has been hypothesized that myelin deficits observed following developmental
inflammation are due to oligodendrocyte progenitor cell damage. Cai et al. (2003)
speculated that a loss of OL progenitors contributed to the deficit in MBP on PND8
following maternal rat LPS exposure on GD18 -19. Further work suggested that LPS-
activated microglia induced OL cell death and impaired OL development (Pang et al., 2010).
Delayed cell death was attenuated with blocking TNFα activity and the impaired
development by ciliary neurotrophic factor (CNTF). Marmur et al (1998) demonstrated that
density-dependent potentiation of OL maturation is mediated by environmental signals such
as cytokines that activate gp130/leukemia inhibitory factor β receptors and CNTF. In this
regard, IL-6 signaling has been associated with early differentiation OLs that may shift the
process of myelination. For example, IL-6R/IL-6 chimera protein induced cultured pre-OL
differentiation into mature oligodendroglia, promoted survival, and increased the number of
highly arborized OLs (Valerio et al., 2002) potentially due to premature cell-cycle exit and
early differentiation of OL progenitors (Zhang et al., 2004). Similar results have been
reported in vivo with intracervical injections of LPS (0.1 mg/kg) on GD15 promoting
generation of OPCs (Poggi et al., 2005). In contrast to the Pang et al (2010) study, the direct
administration of HIL-6 did not activate microglia nor did it elevate TNFα, suggesting an
absence of the LPS-mediated mechanisms for OPC death. Rather, it is of greater likelihood
that the injection of HIL-6 on PND4 facilitated premature differentiation of OPCs, shifting
the normal pattern of myelination. In addition to the direct actions on cultured OLs (Valerio
et al., 2002), HIL-6 promotes neurotrophin expression in astrocytes (März et al., 1999) that
may in turn promote OL maturation. An alternative or additional player is the activation of
glutamate receptor signaling as this was detected as a top canonical pathway identified in
HIL-6 mice and both glutamate and N-methyl-D-aspartate stimulate stem cell OL
differentiation promoting maturation and myelination (Cavaliere et al., 2012).
Premature maturation of OLs could alter the accurate matching of myelin segments to
axonal surfaces. Given the role of MAG to facilitate axon/OL interactions, elevated MAG
mRNA seen during pre-weaning may represent an earlier induction of myelination that
could be indicative of or influence OL maturation. The gene encoding PLP is expressed in
mature OLs but also in OPCs (Gudz et al., 2006) and the protein can function in cell
migration (Fulton et al., 2010). Thus, changes observed in PLP mRNA levels in the HIL-6
mice may also represent changes in OL development and migration along the axon. A
functional shift in OLs is also suggested by changes in the non-hydroxylated fatty acid
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(NFA)-cerebroside sub-fraction of myelin as a specific enzymatic pathway particular to
immature cerebral OLs (Hof and Csiza, 1982). The specific increases in the NFA-
cerebroside sub-fraction and reductions in FA2H and CGT mRNA levels observed with
HIL-6 suggest altered enzyme activity for alpha-hydroxylation of fatty acids and/or turnover
of galactosphingolipids in cerebral OLs. Alternatively, the mRNA pattern and the decreased
myelin process complexity could represent a change in the underlying axon.
These results contribute to our understanding of the complex interactive nature of the
inflammatory response in the developing brain. We now demonstrate the potential for IL-6
to mediate selective effects on the post-natally developing brain in the absence of systemic
immune responses, induction of a pro-inflammatory cytokine cascade, or cell death. The
pattern of changes suggests a role for IL-6 signaling in influencing the establishment of
social and environmental interactive patterns for use later in life. Whether this can be linked
to reactivity and social behavioral changes observed in animal models of
neurodevelopmental disorders is an area for future research.
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Summary scores of preweaning neurobehavioral assessment. (A) hyperkinesias [0–3]. (B)
pivot locomotor reaction to stimulation. (C) early emergence of straight-line locomotion. (D)
Normal motor behaviors. (E) heightened motor reactions (running, jumping, leaping,
stereotypic air sniffing). (F) General reactivity to handling. (G) reaction to startle stimulus.
Bars represent % of mice (n=12/post-natal (P) age/group) exhibiting selected behaviors.
Spearman’s Rank Order correlation for HIL-6 dose (0, 5, 10 ng) by scale score (range 0–3 or
0–4) within post-natal age; #p<0.10, *p<0.05, **p<0.01, ***p<0.001.
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Quantitative real-time PCR (qRT-PCR) for cytokines in the hippocampus. Mice were
injected with vehicle (white bar) or HIL-6 (5ng; dark bar) at PND4 and tissue collected at
PND5. Data are presented as mean fold increase (±SEM) over the average control value for
each transcript. *significantly different from controls p<0.05.
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RNase protection assay for (A) acute response genes and inflammatory cytokines ICAM-1,
iNOS, A20, MAC-1 and EB22 (B) Interleukin 1 related genes and (C) TNF and IL-6 related
genes on total RNA isolated from cortex at PND5 and 11 from mice injected with vehicle or
HIL-6 5ng at PND4. Values represent normalized mean ratio of pixel volume determined by
phosphor-imaging for each transcript (± SE) to corresponding L32. *Significantly different
across age within exposure group, p<0.05.
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Ingenuity IPA network association of microarray analysis changes in gene transcripts related
to MBP in the cortex at PND8 as altered by PND4 HIL-6 exposure. Red indicates down-
regulated (FAM40B, STRN, PFDN5, EPN2, CCT3, TUBB2A, P38MAPK, Defa3, GJB6,
MAG, MBP) and Green indicates up-regulated, with no change in hexokinase, Alpha
Actinin, Ppp2c. Symbols are derived from Ingenuity network analysis: transcription
regulator transporter  complex/group other enzyme  peptidase
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(A) qRT-PCR for myelin specific transcripts in the cortex at various postnatal days (P)
relevant to the developmental profile of each: NG2 (P5, 8, 16), PLP/DM20 (P5, 11, 24), and
MAG (P5, 16, 24) of mice injected at P4 with vehicle (white bars) or 5ng HIL-6 (dark bars).
ANOVA indicated a main effect of HIL-6 for PLP/DM20 and MAG. *significant post-hoc
analysis with Bonferroni correction for multiple comparisons (p=0.014) as compared to
vehicle. (B) NFA cerebrosides as a percent of total cerebrosides (NFA-cerebroside fraction)
in adult mice injected at PND4 with either vehicle or HIL-6 (5 ng). Data represents the mean
% value ± SEM. *significantly different from controls (p<0.05).
(C–D) Representative photomicrographs of immunostaining for myelin basic protein (MBP,
1:500, 20hr, 4°C) as detected by NBT/BCIP. Staining intensity and complexity of MBP
myelin tracts increased with age (C: PND16 [Suppl. Fig. 5]; D: PND24). Branch points
observed in the HIL-6 mice suggested less complexity of myelinated fibers.
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(A–B) Light/dark place preference. (A) Number of entries into the dark chamber over a 10-
min test session. (B) Mean duration (sec) per individual entry. Data represents mean ± SEM.
(C) Passive avoidance performance. Data represents the mean ± SEM latency to enter the
dark chamber on test day. Con – white bars; 5 ng HIL-6 -dark bars *statistically significant
from control *p<0.05; ** p<0.01.
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(A) Startle response amplitude in PND25 mice injected at PND4 [Control – white bar;
HIL-6 5 ng – dark bar]. Data represents the mean over 6 trials. (B) Pre-pulse startle
inhibition across pre-pulse stimulus intensities. Data represent the mean ± SEM.
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Social behavior of adult mice injected with vehicle (Con) or HIL-6 (5ng) on PND4. Social
Approach: (A) total time (sec) spent in contact with (B) sniffing unfamiliar mouse compared
to empty wire cage. Social Novelty: (C) total time (sec) spent in contact with (D) sniffing
familiar mouse compared to stranger. Data shown are mean ± SEM (n=12). *p<0.05;
**p<0.01; ***p<0.001 statistical difference between stranger and empty cage or familiar
and stranger mouse within control and HIL-6 groups.
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Motor activity (A,B) and MWM (C,D) in adult mice injected on PND4 with vehicle
(Control) or 5ng HIL-6. (A) Total ambulation distance (cm) travelled (B) number of rears
occurring during 5-min epochs for 60 min. Data represent mean ± SEM. (C) Latency to find
hidden platform across 5 days of training. Data shown are mean ± SEM of 4 trials/day. (D)
Probe trial - % time (of 1-min) spent in each quadrant. (E) Reversal - latency to find hidden
platform. Data shown are means ± SEM of 4 trials per session.
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TABLE 1
Microarray Analysis of Cortex
Top Canonical Pathways p-valuea Ratiob
Glutamate Receptor Signaling 0.00038 11/69
Axonal Guidance Signaling 0.00095 39/430
TOP MOLECULES
Up-Regulated Fold-Changec
KDM5B – lysine (K)-specific demethylase 5B 8.26
PRPF4B – alcohol group acceptor phosphotransferase, snRNP 7.93
BECN1 – beclin 1, autophagy related 7.91
STK4 – serine/threonine kinase 4 7.84
BAZ1A – bromodomain adjacent to zinc finger domain, 1A 7.63
ROBO3 – roundabout, axon guidance receptor, homolog 3 7.18
CYP – cytochrome P450, family 7, subfamily B, polypeptide 1 6.99
PISD - phosphatidylserine decarboxylase 6.90
IKBKB - inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase β 6.60
MESDC2 – mesoderm development candidate 2 6.30
Down-Regulated Fold-Change
FAM40B – family with sequence similarity 40, member B 9.15
MBP – myelin basic protein 7.75
PDE10A – 3′,5′-cyclic-nucleotide phosphodiesterase, Pde 7.08
ARPC3 – actin related protein 2/3 complex, subunit 3, 21kDa 7.05
LMO4 – LIM domain only 4 6.80
SLC35D3 – solute carrier family 35, member D3 6.75
SEMA7a – semaphoring 7A, GPI membrane anchor 6.58
CAMK2A – calcium/calmodulin-dependent protein kinase II alpha 6.48
MID1 – midline 1 6.07
GNG7 – G protein beta gamma 5.69
a
Canonical pathways were determined by Ingenuity using Benjamini-Hochberg multiple testing correction to determine p value.
b
The ratio represents the number of focused molecules as a function of the total number of molecules in that process.
c
Fold change relative to vehicle control.
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